Skip to content

Evaluation of Mitral Valve Insufficiency Under General Anesthesia

Evaluation of Mitral Valve Insufficiency Under General Anesthesia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05736289
Acronym
MITIGATE
Enrollment
50
Registered
2023-02-21
Start date
2023-02-13
Completion date
2025-07-01
Last updated
2023-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Regurgitation, Mitral Valve Disease, Mitral Valve Insufficiency

Brief summary

Observational study in adult humans undergoing surgical or cardiological intervention for mitral valve insufficiency. Investigators aim to evaluate hemodynamic changes on an arterial pressure waveform level in patients before and after mitral valve intervention using Nexfin (BMEYE, Amsterdam, the Netherlands) continuous non-invasive hemodynamic monitoring, using finger cuff based technology to register beat-to-beat data

Interventions

None listed

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients with moderate or severe mitral valve insufficiency undergoing cardiothoracic surgery or percutaneous treatment for this condition * Adult patients (\>18 years)

Exclusion criteria

* No informed consent

Design outcomes

Primary

MeasureTime frameDescription
Arterial pressure waveform changesBefore and during general anesthesia for mitral valve repair or replacement, ranging from 1 to 5 hours.Arterial pressure waveform as recorded by a continuous non invasive hemodynamic monitoring system.

Countries

Netherlands

Contacts

Primary ContactJohan TM Tol, MD
j.tol2@amsterdamumc.nl020 566 6478
Backup ContactDenise P Veelo, MD PhD
d.p.veelo@amsterdamumc.nl020 566 6478

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026